Skip to NavigationSkip to content

News

GlaxoSmithKline Chief Executive Jean-Pierre Garnier says he believes the company has urned a cornerin halting the decline in its R&D productivity...
Johnson & Johnson is to expand its biotech capabilities with a $2.4 billion purchase of US company Scios.
Serono is to withdraw one of its hormone products from the UK after a case of variant Creutzfeldt-Jakob disease was confirmed in Italy, where the...
AstraZeneca has submitted its lung cancer drug Iressa for approval in Europe, despite concerns about side-effects.
Pressure from shareholders has prompted UK vaccines group PowderJect to split the roles of chairman and chief executive.
Boehringer Ingelheim has begun a global phase III trial for a new drug it hopes will be effective for HIV patients who have become resistant to...
Former ImClone boss Samuel Waksal has agreed to pay $800,000 to settle some of the charges brought against him by the US Securities & Exchange...
GlaxoSmithKline is to raise the issue of Chief Executive Jean-Pierre Garnier pay once again this week, saying it is intended as part of a wider...
The European Commission has restarted its review of Pfizer merger with Pharmacia, and now expects to complete the investigation of the $60 billion...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches